Rhenman & Partners Asset Management AB as of March 31, 2017
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 104 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 4.1 | $26M | 1.8M | 14.78 | |
| Esperion Therapeutics (ESPR) | 3.0 | $19M | 543k | 35.31 | |
| Biogen Idec (BIIB) | 2.9 | $19M | 68k | 273.43 | |
| Glaukos (GKOS) | 2.6 | $17M | 326k | 51.30 | |
| Amgen (AMGN) | 2.6 | $16M | 100k | 164.07 | |
| Incyte Corporation (INCY) | 2.4 | $15M | 115k | 133.67 | |
| Abiomed | 2.3 | $15M | 117k | 125.20 | |
| Medtronic (MDT) | 2.3 | $15M | 181k | 80.56 | |
| Regeneron Pharmaceuticals (REGN) | 2.3 | $14M | 37k | 387.51 | |
| Eli Lilly & Co. (LLY) | 2.3 | $14M | 170k | 84.11 | |
| Gilead Sciences (GILD) | 2.2 | $14M | 207k | 67.92 | |
| Allergan | 2.2 | $14M | 59k | 238.92 | |
| Exelixis (EXEL) | 2.2 | $14M | 630k | 21.67 | |
| Alexion Pharmaceuticals | 2.1 | $14M | 112k | 121.24 | |
| Intra Cellular Therapies (ITCI) | 1.8 | $12M | 716k | 16.25 | |
| Celgene Corporation | 1.8 | $12M | 93k | 124.43 | |
| Endologix | 1.8 | $12M | 1.6M | 7.24 | |
| Pfizer (PFE) | 1.8 | $12M | 335k | 34.21 | |
| Nektar Therapeutics | 1.8 | $11M | 470k | 23.47 | |
| BioMarin Pharmaceutical (BMRN) | 1.7 | $11M | 125k | 87.78 | |
| Bristol Myers Squibb (BMY) | 1.7 | $11M | 201k | 54.38 | |
| UnitedHealth (UNH) | 1.7 | $11M | 65k | 164.02 | |
| Nevro (NVRO) | 1.7 | $11M | 113k | 93.70 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.6 | $10M | 95k | 109.35 | |
| CVS Caremark Corporation (CVS) | 1.6 | $10M | 130k | 78.50 | |
| Merck & Co (MRK) | 1.6 | $10M | 160k | 63.54 | |
| CIGNA Corporation | 1.5 | $9.4M | 64k | 146.48 | |
| Hca Holdings (HCA) | 1.5 | $9.3M | 105k | 88.99 | |
| Jazz Pharmaceuticals (JAZZ) | 1.4 | $8.8M | 60k | 145.13 | |
| Kite Pharma | 1.4 | $8.6M | 110k | 78.49 | |
| Zimmer Holdings (ZBH) | 1.4 | $8.5M | 70k | 122.11 | |
| Abbvie (ABBV) | 1.3 | $8.5M | 130k | 65.16 | |
| Alkermes (ALKS) | 1.3 | $8.2M | 140k | 58.50 | |
| Supernus Pharmaceuticals (SUPN) | 1.1 | $7.2M | 230k | 31.30 | |
| Alnylam Pharmaceuticals (ALNY) | 1.1 | $6.7M | 130k | 51.25 | |
| Aetna | 1.1 | $6.6M | 52k | 127.56 | |
| Humana (HUM) | 1.0 | $6.6M | 32k | 206.12 | |
| Hologic (HOLX) | 1.0 | $6.4M | 150k | 42.55 | |
| Express Scripts Holding | 1.0 | $6.3M | 96k | 65.91 | |
| Centene Corporation (CNC) | 1.0 | $6.2M | 88k | 71.26 | |
| Xencor (XNCR) | 1.0 | $6.2M | 260k | 23.92 | |
| Anthem (ELV) | 1.0 | $6.2M | 38k | 165.37 | |
| Cardinal Health (CAH) | 1.0 | $6.1M | 75k | 81.55 | |
| Thermo Fisher Scientific (TMO) | 1.0 | $6.1M | 40k | 153.60 | |
| Dynavax Technologies (DVAX) | 0.9 | $5.9M | 985k | 5.95 | |
| Edwards Lifesciences (EW) | 0.9 | $5.6M | 60k | 94.07 | |
| AmerisourceBergen (COR) | 0.9 | $5.6M | 63k | 88.51 | |
| Sage Therapeutics (SAGE) | 0.8 | $5.2M | 73k | 71.07 | |
| Abbott Laboratories (ABT) | 0.8 | $5.1M | 115k | 44.41 | |
| Lion Biotechnologies | 0.8 | $4.8M | 650k | 7.45 | |
| Dex (DXCM) | 0.8 | $4.8M | 57k | 84.73 | |
| Portola Pharmaceuticals | 0.8 | $4.7M | 121k | 39.19 | |
| Endo International | 0.7 | $4.5M | 402k | 11.16 | |
| Universal Health Services (UHS) | 0.7 | $4.4M | 35k | 124.46 | |
| Revance Therapeutics | 0.7 | $4.4M | 210k | 20.80 | |
| Rigel Pharmaceuticals | 0.7 | $4.2M | 1.3M | 3.31 | |
| NxStage Medical | 0.7 | $4.1M | 154k | 26.83 | |
| Omnicell (OMCL) | 0.6 | $4.0M | 99k | 40.65 | |
| Aerie Pharmaceuticals | 0.6 | $3.9M | 85k | 45.35 | |
| Fibrogen | 0.6 | $3.8M | 154k | 24.65 | |
| DaVita (DVA) | 0.6 | $3.7M | 55k | 67.96 | |
| Walgreen Boots Alliance | 0.6 | $3.7M | 45k | 83.04 | |
| Neurocrine Biosciences (NBIX) | 0.6 | $3.7M | 85k | 43.31 | |
| Mylan Nv | 0.6 | $3.5M | 90k | 38.99 | |
| Intercept Pharmaceuticals In | 0.5 | $3.4M | 30k | 113.10 | |
| Macrogenics (MGNX) | 0.5 | $3.3M | 175k | 18.60 | |
| Array BioPharma | 0.5 | $3.1M | 350k | 8.94 | |
| Laboratory Corp. of America Holdings | 0.5 | $3.1M | 22k | 143.48 | |
| Intuitive Surgical (ISRG) | 0.5 | $3.1M | 4.0k | 766.50 | |
| Immunomedics | 0.5 | $3.1M | 480k | 6.47 | |
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $3.1M | 90k | 34.38 | |
| Radius Health | 0.5 | $2.9M | 75k | 38.65 | |
| Tetraphase Pharmaceuticals | 0.4 | $2.8M | 300k | 9.19 | |
| Adamas Pharmaceuticals | 0.4 | $2.7M | 155k | 17.50 | |
| Keryx Biopharmaceuticals | 0.4 | $2.6M | 425k | 6.16 | |
| Chimerix (CMRX) | 0.4 | $2.6M | 400k | 6.38 | |
| Coherus Biosciences (CHRS) | 0.4 | $2.4M | 111k | 21.15 | |
| Halozyme Therapeutics (HALO) | 0.3 | $2.2M | 170k | 12.96 | |
| Bioverativ Inc Com equity | 0.3 | $1.7M | 31k | 54.45 | |
| Insulet Corporation (PODD) | 0.2 | $1.5M | 35k | 43.09 | |
| Regulus Therapeutics | 0.2 | $980k | 594k | 1.65 | |
| Becton, Dickinson and (BDX) | 0.1 | $917k | 5.0k | 183.40 | |
| Tesaro | 0.1 | $769k | 5.0k | 153.80 | |
| Achillion Pharmaceuticals | 0.1 | $699k | 166k | 4.21 | |
| Concert Pharmaceuticals I equity | 0.1 | $513k | 30k | 17.04 | |
| Catabasis Pharmaceuticals | 0.1 | $497k | 311k | 1.60 | |
| JPMorgan Chase & Co. (JPM) | 0.1 | $425k | 4.8k | 87.86 | |
| Adverum Biotechnologies | 0.1 | $416k | 154k | 2.70 | |
| Orexigen Therapeutics | 0.1 | $413k | 120k | 3.44 | |
| Exxon Mobil Corporation (XOM) | 0.1 | $396k | 4.8k | 82.11 | |
| Wells Fargo & Company (WFC) | 0.1 | $407k | 7.3k | 55.72 | |
| Halliburton Company (HAL) | 0.1 | $380k | 7.7k | 49.24 | |
| Ocular Therapeutix (OCUL) | 0.1 | $371k | 40k | 9.28 | |
| Microsoft Corporation (MSFT) | 0.1 | $316k | 4.8k | 65.93 | |
| International Business Machines (IBM) | 0.1 | $308k | 1.8k | 174.41 | |
| Qualcomm (QCOM) | 0.1 | $308k | 5.4k | 57.38 | |
| Anheuser-Busch InBev NV (BUD) | 0.1 | $308k | 2.8k | 109.76 | |
| STAAR Surgical Company (STAA) | 0.0 | $281k | 29k | 9.79 | |
| Ford Motor Company (F) | 0.0 | $262k | 23k | 11.64 | |
| Mirati Therapeutics | 0.0 | $260k | 50k | 5.20 | |
| Tandem Diabetes Care | 0.0 | $281k | 234k | 1.20 | |
| Threshold Pharmaceuticals | 0.0 | $115k | 202k | 0.57 | |
| Anthera Pharmaceutcls | 0.0 | $84k | 200k | 0.42 | |
| Ophthotech | 0.0 | $88k | 24k | 3.68 |
